Copyright
©The Author(s) 2023.
World J Cardiol. Jul 26, 2023; 15(7): 342-353
Published online Jul 26, 2023. doi: 10.4330/wjc.v15.i7.342
Published online Jul 26, 2023. doi: 10.4330/wjc.v15.i7.342
Table 1 Demographic characteristics and disease category of the patients (n = 687)
Total, n = 687 | Female, n = 171 | Male, n = 516 | P value | |
Age (years) | 59.6 ± 9.58 | 62.4 ± 8.9 | 58.6 ± 9.6 | < 0.0001 |
CHD category, n (%) | ||||
CABG | 153 (22.3) | 41 (24) | 112 (22) | > 0.05 |
PCI | 351 (51.1) | 71 (42) | 280 (54) | 0.004 |
ACS | 172 (25.0) | 27 (16) | 145 (28) | 0.001 |
SAP | 249 (36.2) | 82 (48) | 167 (32) | 0.0002 |
HA | 271 (39.4) | 68 (40) | 203 (39) | > 0.05 |
CR | 104 (15.1) | 19 (11.1) | 85 (16.5) | > 0.05 |
Table 2 Cardiovascular risk factors stratified by sex, n (%)
Total, n = 687 | Female, n = 171 | Male, n = 516 | P value | |
Smoking history | ||||
Current smoker | 169 (24.6) | 3 (1.8) | 166 (32) | < 0.00001 |
Ex-smoker | 169 (24.6) | 2 (1.2) | 167 (32) | < 0.00001 |
Never smoked | 314 (45.7) | 165 (96.5) | 149 (29) | < 0.00001 |
Unknown | 35 (5.1) | 1 (0.6) | 34 (7) | |
Physical activity | ||||
Less than below | 223 (32.5) | 66 (38.6) | 157 (30.4) | > 0.05 |
Moderate | 324 (47.2) | 74 (43.3) | 250 (48.4) | > 0.05 |
More than above | 82 (11.9) | 19 (11.1) | 63 (12.2) | > 0.05 |
Unknown | 58 (8.4) | 12 (7.02) | 46 (8.9) | |
Family history of premature CVD | ||||
Yes | 265 (38.6) | 58 (33.9) | 207 (40.1) | > 0.05 |
No | 355 (51.7) | 96 (56.1) | 259 (50.2) | > 0.05 |
Unknown | 67 (9.8) | 17 (9.9) | 50 (9.7) | |
Previous history of | ||||
Hypertension | 537 (78.2) | 142 (83) | 395 (76.6) | > 0.05 |
Dyslipidaemia | 255 (37.1) | 60 (35.1) | 195 (37.8) | > 0.05 |
Diabetes | 310 (45.1) | 95 (55.6) | 215 (41.7) | 0.002 |
Table 3 Clinical measurements and laboratory data of the patients (mean ± SD)
Total | Female | Male | P value | |
Systolic BP (mmHg) | n = 663 | n = 164 | n = 499 | |
138.4 (18.9) | 142.4 (1.4) | 137.1 (17.9) | 0.004 | |
Diastolic BP (mmHg) | n = 658 | n = 162 | n = 496 | |
82.9 (10.7) | 82.7 (11.5) | 82.8 (10.4) | > 0.05 | |
Heart rate (bmp) | n = 649 | n = 156 | n = 493 | |
77.6 (12.7) | 78.5 (12.0) | 77.3 (12.9) | > 0.05 | |
BMI (kg/m2) | n = 216 | n = 50 | n = 166 | |
28.4 (3.02) | 29.6 (3.4) | 28 (2.8) | 0.002 | |
WC (cm) | n = 30 | n = 13 | n = 17 | |
101 (12.9) | 100.8 (15.2) | 101.0 (11.3) | > 0.05 | |
TC (mg/dL) | n = 347 | n = 86 | n = 261 | |
193.9 (52.4) | 200.4 (50.7) | 192.3 (53) | > 0.05 | |
LDL-C (mg/dL) | n = 371 | n = 101 | n = 270 | |
111.2 (49.6) | 118.3 (49.7) | 108.6 (49.3) | > 0.05 | |
HDL-C (mg/dL) | n = 185 | n = 50 | n = 135 | |
53.4 (13.8) | 54.4 (13.1) | 53 (14.1) | > 0.05 | |
TG (mg/dL) | n = 367 | n = 93 | n = 274 | |
161.0 (76.0) | 169.8 (77.8) | 158 (75.4) | > 0.05 | |
BG (mg/dL) | n = 277 | n = 73 | n = 204 | |
146.7 (71.5) | 162.7 (79.9) | 141 (67.5) | 0.04 | |
HbA1c (%) | n = 137 | n = 44 | n = 93 | |
7.71 (1.72) | 8.1 (2.0) | 7.5 (1.5) | > 0.05 |
Table 4 Rates of uncontrolled blood pressure in different categories of arterial hypertension
BP category, n = 658 | Total (%) | Female (%) | Male (%) | P value |
SDH | 27.5 | 27.8 | 27.4 | 0.929 |
ISH | 20.9 | 26.8 | 18.8 | 0.029 |
IDH | 6.8 | 6.8 | 6.9 | 0.977 |
Table 5 Medication use rate in patients with known coronary artery disease (%)
Medications | Total | Male | Female | P value |
n = 687 | n = 516 | n = 171 | ||
Antiplatelets | 84.6 | 85.3 | 82.5 | 0.377 |
Beta blockers | 53.3 | 55.2 | 47.4 | 0.074 |
ACE inhibitors | 51.2 | 49.0 | 57.9 | 0.044 |
Ca antagonists | 29.3 | 28.7 | 31.0 | 0.565 |
ARB-s | 6.0 | 5.8 | 6.4 | 0.767 |
Diuretics | 22.3 | 20.5 | 27.5 | 0.059 |
Other antihypertensives | 2.3 | 1.9 | 3.5 | 0.238 |
Nitrates | 21.3 | 7.6 | 62.6 | < 0.00001 |
Insulin | 7.6 | 6.4 | 11.1 | 0.043 |
Oral hypoglycaemics | 23 | 20.9 | 29.2 | 0.025 |
Statins | 73.9 | 76.4 | 66.7 | 0.012 |
Other lipid lowering | 1.3 | 1.2 | 1.8 | 0.555 |
- Citation: Gabulova R, Marzà-Florensa A, Rahimov U, Isayeva M, Alasgarli S, Musayeva A, Gahramanova S, Ibrahimov F, Aliyev F, Imanov G, Rasulova R, Vaartjes I, Klipstein-Grobusch K, Graham I, Grobbee DE. Risk factors in cardiovascular patients: Challenges and opportunities to improve secondary prevention. World J Cardiol 2023; 15(7): 342-353
- URL: https://www.wjgnet.com/1949-8462/full/v15/i7/342.htm
- DOI: https://dx.doi.org/10.4330/wjc.v15.i7.342